AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home mLife Article
PDF (2.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Research | Open Access

EmbB and EmbC regulate the sensitivity of Mycobacterium abscessus to echinomycin

Jing He1,2,3,4,# , Yamin Gao2,3,4,5,#, Jingyun Wang6,7, H. M. Adnan Hameed2,3,4,5 ( ), Shuai Wang2,3,4,5, Cuiting Fang2,3,4,5, Xirong Tian2,3,4,5, Jingran Zhang2,3,4,8, Xingli Han2,3,4,5, Yanan Ju2,3,4,8, Yaoju Tan9, Junying Ma7, Jianhua Ju7, Jinxing Hu9( ), Jianxiong Liu9( ), Tianyu Zhang1,2,3,4,5,8,9 ( )
Institute of Physical Science and Information Technology, Anhui University, Hefei, China
State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
China-New Zealand Joint Laboratory on Biomedicine and Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
University of Chinese Academy of Sciences, Beijing, China
School of Pharmacy, Institute of Marine Drug, Guangxi University of Traditional Chinese Medicine, Nanning, China
CAS Key Laboratory of Tropical Marine Bio-Resources and Ecology, RNAM Center for Marine Microbiology, Guangdong Key Laboratory of Marine Materia Medica, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou, China
School of Life Sciences, University of Science and Technology of China, Hefei, China
State Key Laboratory of Respiratory Disease, Guangzhou Chest Hospital, Guangzhou, China

#Jing He and Yamin Gao contributed equally to this work.

Show Author Information

Abstract

Treatment of Mycobacterium abscessus (Mab) infections is very challenging due to its intrinsic resistance to most available drugs. Therefore, it is crucial to discover novel anti-Mab drugs. In this study, we explored an intrinsic resistance mechanism through which Mab resists echinomycin (ECH). ECH showed activity against Mab at a minimum inhibitory concentration (MIC) of 2 µg/ml. A ΔembC strain in which the embC gene was knocked out showed hypersensitivity to ECH (MIC: 0.0078–0.0156 µg/ml). The MICs of ECH-resistant strains screened with reference to ΔembC ranged from 0.25 to 1 µg/ml. Mutations in EmbB, including D306A, D306N, R350G, V555I, and G581S, increased the Mab's resistance to ECH when overexpressed in ΔembC individually (MIC: 0.25–0.5 µg/ml). These EmbB mutants, edited using the CRISPR/Cpf1 system, showed heightened resistance to ECH (MIC: 0.25–0.5 µg/ml). The permeability of these Mab strains with edited genes and overexpression was reduced, as evidenced by an ethidium bromide accumulation assay, but it remained significantly higher than that of the parent Mab. In summary, our study demonstrates that ECH exerts potent anti-Mab activity and confirms that EmbB and EmbC are implicated in Mab's sensitivity to ECH. Mutation in EmbB may partially compensate for a loss of EmbC function.

References

【1】
【1】
 
 
mLife
Pages 459-470

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
He J, Gao Y, Wang J, et al. EmbB and EmbC regulate the sensitivity of Mycobacterium abscessus to echinomycin. mLife, 2024, 3(3): 459-470. https://doi.org/10.1002/mlf2.12139

700

Views

4

Downloads

4

Crossref

6

Web of Science

6

Scopus

0

CSCD

Received: 25 December 2023
Accepted: 11 May 2024
Published: 30 September 2024
© 2024 The Author(s). mLife published by John Wiley & Sons Australia, Ltd on behalf of Institute of Microbiology, Chinese Academy of Sciences.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.